<SEC-DOCUMENT>0001193125-20-312895-index.html : 20201208
<SEC-HEADER>0001193125-20-312895.hdr.sgml : 20201208
<ACCEPTANCE-DATETIME>20201208172554
ACCESSION NUMBER:		0001193125-20-312895
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20201208
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201208
DATE AS OF CHANGE:		20201208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silverback Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001671858
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				811489190
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39756
		FILM NUMBER:		201376156

	BUSINESS ADDRESS:	
		STREET 1:		500 FAIRVIEW AVENUE NORTH, SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
		BUSINESS PHONE:		206-456-2900

	MAIL ADDRESS:	
		STREET 1:		500 FAIRVIEW AVENUE NORTH, SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d66270d8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: d66270d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d66270dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
Document 2 - file: d66270dex31.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>d66270dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
Document 3 - file: d66270dex32.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d66270dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 4 - file: d66270dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g66270g77a86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g66270g77a86.jpg

</DOCUMENT>
</SEC-DOCUMENT>